The trial in numbers
12601 Patients randomised
1780 Total number of patients randomised in the Golden hour to date
399 Patients to recruit by 31 January 2019
8 days to go!
Every minute counts
LATEST BLOG POSTS
A message from the team at The Royal London Hospital, CRASH-3's highest recruiting hospital in the UK. REMEMBER: *ALL CRASH-3 TREATMENT PACKS EXPIRE 31/01/2019 AND MUST BE DESTROYED ON THIS DATE - USE IT OR LOSE IT! *...
A message from Salman Ahmad, our data collector at Lahore General Hospital, CRASH-3's highest recruiting hospital. REMEMBER: *ALL CRASH-3 TREATMENT PACKS EXPIRE 31/01/2019 AND MUST BE DESTROYED ON THIS DATE - USE IT OR LOSE IT! *...
12,601 patients recruited
28 recruiting countries
171 hospitals and medical centres
ABOUT THE TRIAL
The CRASH3 trial aims to provide the research based information to prevent death by Traumatic Brain Injury.
The CRASH3 trial is testing whether tranexamic acid, a blood clot stabiliser that was discovered in Japan in the 1950’s, can become an essential tool for fighting excessive bleeding in the brain after Traumatic Brain Injury.more info
If you were a patient randomised into this trial and would like further information about your treatment, click below.
The staff at the hospital where you were being treated for your traumatic brain injury should have given you an information leaflet about the CRASH3 trial. If you have any questions or concerns about your treatment in the hospital, please contact your doctor in the first instance.more info